JUN 20, 2018 7:42 PM PDT

The Cause of a Rare Neurological Disease is Identified

WRITTEN BY: Carmen Leitch

The causes of rare diseases can be difficult to uncover. A recent investigation by scientists at UT Southwestern involved over 1,200 participants and sought to find the gene responsible for a debilitating brain disease that causes blindness and paralysis, called neuromyelitis optica (NMO). The scientists are hopeful that their work, which was published in Nature Communications, will lead to good treatments for the disease. It also demonstrates the power that DNA storage banks have to inform our understanding of unusual disorders.


 "This outcome shows that doing in-depth research pays off, and more studies like this may be needed to find the problem behind other rare conditions," said Dr. Benjamin Greenberg, an internationally recognized myelitis expert at UT Southwestern's Peter O'Donnell Jr. Brain Institute. "By taking a rare disease and doing more than just reading every third or fourth page of genetic code, we have modeled NMO in a much more accurate way."

Patients with NMO have a problem with their immune system that causes it to attack cells in the spine and optic nerve. While many of those affected are able to regain function with physical therapy and medication, many others are misdiagnosed. When the disease is not correctly identified, relapses and additional problems can happen, and it might be fatal.

By using whole-genome sequencing, the scientists uncovered a change in a gene that was linked to an increase in the risk of the disease. The gene makes a protein that attaches to antibodies; the protein can then interfere with what the antibody is bound to, which is often pathogenic microbes. In the NMO disorder, the antibodies improperly attach to places in the nervous system instead. 

This genetic study could be considered along with clinical data to identify the patients that won’t benefit from typical treatments.

"Some patients go into remission and others don't, yet we haven't known why," Dr. Greenberg explained. "What we can do now is look at the DNA and determine if that has anything to do with why drugs are not working."

 NMO is one of the least common autoimmune diseases that impact the spinal cord and brain. Because so few people are affected, it does not attract a lot of research attention. This work has demonstrated the value of researching rare disorders, however.  

NMO is among several thousand rare diseases that cumulatively affect 30 million Americans yet individually don't involve large enough populations to attract widespread research efforts. As little as 0.3 percent of every one hundred thousand Americans have NMO - making it one of the most uncommon autoimmune diseases involving the brain and spinal cord. 

"To target a disease as rare as this, to put this much technology behind trying to understand the disease - it hasn't been done before," Dr. Greenberg said. "This study has given insights into this condition that aren't just new but are distinctly different from other studies."


Sources: AAAS/Eurekalert! Via UT Southwestern Medical Center, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
FEB 14, 2020
Cancer
FEB 14, 2020
Cataloging Cancer: DNA fingerprints at work
New research published as part of a global Pan-Cancer Project highlights the world’s most comprehensive catalog to ...
FEB 25, 2020
Genetics & Genomics
FEB 25, 2020
Improving Gene Therapy With Plant-Based Relatives of Cholesterol
Cholesterol analogs give nanoparticles a shape that helps them get where they need to go.
FEB 27, 2020
Cell & Molecular Biology
FEB 27, 2020
Caloric Restriction Changes Gene Expression, Reduces Inflammation
New research has added to the evidence that suggests that dietary restriction has health benefits.
MAR 15, 2020
Genetics & Genomics
MAR 15, 2020
Insight Into Neuronal Growth and Memory Formation
Now scientists have learned more about the transport of mRNA in neurons, and the storage and formation of memories.
APR 04, 2020
Cannabis Sciences
APR 04, 2020
Only 50% Cannabis Genome Has Been Mapped
As more and more jurisdictions are decriminalizing cannabis usage, its popularity both for medicinal and recreational us ...
APR 21, 2020
Genetics & Genomics
APR 21, 2020
A 2020 Census for Microbes in Florida Springs
Water sources are vital to communities and wildlife alike, and it's important to monitor their health.
Loading Comments...